Fried Divine Comedy, featuring anti-cancer cockroach and phallic fungus
This is a follow-up to the previous article, about a misconduct investigation at the Cardiff University in UK into theContinue Reading
By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
This is a follow-up to the previous article, about a misconduct investigation at the Cardiff University in UK into theContinue Reading
The Cardiff University in UK is now investigating two cancer researchers, both senior professors, for suspected scientific misconduct. The evidenceContinue Reading
Before biology became digital, with its -omics and big data, there were mostly gels and microscopy images. The peak of image use in biomedical papers was reached at the turn of the century, those became the golden times of Photoshop-assisted data manipulation. To celebrate that period, I selected an example of the British cancer researcher Paul Workman, President and CEO of the huge Institute of Cancer Research (ICR) in London.
On July 29th 2016, Journal of Biological Chemistry (JBC) retracted a cardiology paper from 2009 for data manipulations. Only someContinue Reading
More bad news for Karl Lenhard Rudolph: misconduct findings and 2 year funding ban from DFG. Good news: the international scientific community stands to him in solidarity, no retractions, even some corrections won’t be implemented.
“The graduate school at University of Texas MD Anderson does not care and keep sending students to his lab, Sood is a member of faculty there. RIO at MDACC doesn’t care because witnesses either left the country or are too afraid to speak.”
‘The results have been replicated by ourselves or others, so the image manipulation is irrelevant.’ – Justin Stebbing, double bluffing
Western blot, a method to separate proteins by size and analyse their relative expression levels, is a much maligned techniqueContinue Reading
Did NAS Member Carol Prives know anything about these suspected manipulations in her lab’s papers? And how will journals act on the evidence?
The Swedish Karolinska Institutet (KI) is going through turbulent times. The Paolo Macchiarini scandal sensitised the European elite biomedical research centreContinue Reading









